Related Experiment Video
Updated: May 21, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
SLE with recurrent heart failure and a dermatological clue to another added possibility
Luciano Candilio1, David D'Cruz, Divaka Perera
1Department of Cardiology, St. George's Hospital, London, UK.
Insights
Systemic lupus erythematosus (SLE) can cause myocarditis, leading to heart dysfunction. Scleroderma was suspected as the underlying cause in a patient with refractory SLE myocarditis and characteristic skin findings.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
- Myocarditis, inflammation of the heart muscle, can be a serious cardiac complication of SLE.
- Obstructive coronary artery disease (CAD) must be excluded in patients presenting with chest pain and cardiac biomarkers.
Observation:
- A 36-year-old man with SLE presented with chest pain, ECG changes, and elevated cardiac/inflammatory markers.
- Echocardiography revealed impaired left ventricular (LV) function, and coronary angiography ruled out obstructive CAD.
- Despite treatment for SLE myocarditis with immunosuppressants, his condition showed partial improvement and a relapsing-remitting course with progressive LV dysfunction.
Findings:
- Cardiac MRI demonstrated active inflammation and extensive transmural scarring.
- Endomyocardial biopsy (EMB) showed patchy myocardial fibrosis and low-grade myocarditis, with negative PCR for viral causes.
- Lack of response to immunosuppression and the presence of the "En coup de Sabre" sign suggested scleroderma as the underlying etiology.
Implications:
- This case highlights the importance of considering scleroderma as an underlying cause of refractory myocarditis in SLE patients.
- Aggressive immunosuppression may not always be sufficient for managing autoimmune myocarditis.
- Multimodality imaging and biopsy are crucial for accurate diagnosis and management of complex cardiac conditions in autoimmune diseases.
Abstract:
A 36-year-old man with systemic lupus erythematosus (SLE) presented with chest pain, infero-lateral ST segment elevation on ECG and elevation of cardiac biomarkers and inflammatory markers. Coronary angiography ruled out obstructive coronary artery disease (CAD) but echocardiography showed impairment of regional and global left ventricular (LV) function. He was treated for SLE myocarditis but institution of aggressive immunosuppressant therapy only partially improved his condition, which followed a relapsing and remitting course in subsequent months, with progressive impairment of LV function. Cardiac MRI showed active inflammation and extensive transmural scarring. Endomyocardial biopsy (EMB) demonstrated patchy myocardial fibrosis and low-grade myocarditis and PCR assays excluded viral causes. The lack of response to immunosuppression and the detection of the sign of En coup de Sabre were suggestive of scleroderma as the underlying cause of the myocarditis.
Related Concept Videos
Heart Failure III: Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology